• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the factors regulating the gene expression of vascular wall fibronectin in isolated arteries.

Research Project

Project/Area Number 06670735
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionYokohama City University

Principal Investigator

TAKASAKI Izumi  Yokohama City University, School of Medicine, Associate Prof., 医学部, 講師 (00244492)

Co-Investigator(Kenkyū-buntansha) ISHII Masao  Yokohama City University, School of Medicine, Professor, 医学部, 教授 (90010363)
SHIONOIRI Hiroshi  Yokohama City University, School of Medicine, Associate Prof., 医学部, 講師 (20128599)
GOTOH Eiji  Yokohama City University, School of Medicine, Associate Prof., 医学部, 助教授 (30153753)
Project Period (FY) 1994 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1996: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
KeywordsFibronectin / isolated arteries / gene regulation / Atherosclerosis / Hypertension
Research Abstract

Isolated rat aorta cultured in serum-free medium has been reported to undergo a phenotypic shift to a less differentiated, potentially proliferative state. Using this organ culture system, the expression of an immediate early gene, c-fos, and a component of extracellular matrix, fibronectin (FN), in the aortic wall was studied. A strong induction of c-fos mRNA occurred as early as after 10 min incubation with a peak increase at 1 and 6 hours, declining to a baseline level after 48-hour incubation. Expression of FN was dramatically increased after24h incubation. Balloon dilatation did not alter the aortic mRNA levels for c-fos or FN.Inhibition of protein kinase C (PKC) by H7 decreased the c-fos mRNA by 39.5%. In contrast, CV11974, an angiotensin II type 1 receptor antagonist, or HA1004, a protein kinase A inhibitor, when given alone, did not decrease the c-fos mRNA level. However, when H7, CV11974, and HA1004 were given together, the c-fos mRNA level was decreased by 72.0% (n=3). FN was slightly but significantly induced by intraluminal dilatation with a vessel dilator, which was inhibited by a PKC inhibitor. The strong and prolonged expression of c-fos may have occured as a response to vascular injury given to the aortic wall during the dissection procedure. PKC may play a major role in a signal transduction pathway leading to the induction of c-fos and FN in the aortic wall. Multiple stimuli from different signal transduction systems may be additively or synergistically modulationg the expression of aortic c-fos and FN gene.

Report

(4 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • 1994 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Izumi Takasaki: "Effects of hypertension and aging on fibronectin expression in aorta of Dahl salt-sensitive rats." American Journal of Physiology. 267. H1523-H1529 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 高さき泉: "高血圧性血管障害における細胞外マトリクス(フィブロネクチン)の役割" 医薬ジャーナル. 30. 959-964 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 高さき泉: "細胞外基質の構造と機能-フィブロネクチン" 腎と透析. 37. 1093-1097 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 高さき泉: "高血圧性血管障害と細胞外マトリクス蛋白フィブロネクチン" Therapeutic Research. 16. 120-124 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 成瀬雅彦: "血管壁プロトオンコジーンの発現-バルーンカテーテルを用いた摘出血管における検討-" Therapeutic Research. 16. 4271-4274 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 田村功一: "ラット動脈平滑筋細胞におけるアンジオテンシンIIによる細胞外マトリックスフィブロネクチン遺伝子の発現調節" Therapeutic Research. 18. 190-197 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Izumi Takasaki, et al.: "Effects of hypertension and aging on fibronectin expression in aorta of Dahl salt-sensitive rats" American Journal of Physiology. 267. H1523-H1529 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Izumi Takasaki, et al.: "Roles of extracellular matrix (fibronectin) in hypertensive vascular diseases" Medicine and Drug Journal. 30. 959-964 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Izumi Takasaki, et al.: "Hypertensive vascular diseases and an extracellular matrix, fibronectin" Therapeutic Research. 16. 120-124 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Izumi, Takasaki, et al.: "Atherosclerosis and vascular aging, roles of growth factors and extracellular matrix in pathogenesis and progression." The Yokohama Medical Journal. 46. 702-705 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Masahiko Naruse, Izumi Takasaki, et al.: "Expression of vascular wall proto-oncogene." Therapeutic Research. 16. 4271-4274 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Koh-ichi Sugimoto, Eiji Gotoh, Izumi Takasaki, et al.: "AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats." Clin Exp Pharmacol Physiol. 23. 282-286 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Kouichi Tamura, Izumi Takasaki, et al.: "Angiotensin II-mediated modulation of fibronectin gene expression in rat aortic smooth muscle cells." Therapeutic Research. 18. 190-197 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 田村功一: "ラット大動脈平滑筋細胞におけるアンジオテンシンIIによる細胞外マトリックスフィブロネクチン遺伝子の発現調節" Therapeutic Research. 18・1. 190-197 (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] 高崎泉: "高血圧性血管障害と細胞外マトリクス蛋白フィブロネクチン" Therapeutic Research. 16. 120-124 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] 成瀬雅彦: "血管壁プロトオンコジーンの発現-バルーンカテーテルを用いた摘出血管における検討-" Therapeutic Research. 16. 4271-4274 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Izumi Takasaki: "Effects of hypertension and aging on fibronectin expression in aorta of Dahl salt-sensltive rats." American Journal of Physiology. 267. H1523-H1529 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 高崎 泉: "高血圧性血管障害における細胞外マトリクス(フィブロネクチン)の役割" 医薬ジャーナル. 30. 959-964 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 高崎 泉: "細胞外基質の構造と機能-フィブロネクチン" 腎と透析. 37. 1093-1097 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 高崎 泉: "高血圧性血管障害と細胞外マトリクス蛋白フィブロネクチン" Therapeutic Research. 16. 120-124 (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi